NSMCE2 promotes the occurrence and development of HCC by regulating the SUMOylation of PPARα
Our study uncovered the role of NSMCE2 in the development and progression of HCC, providing new insights into the pathogenesis and potential therapeutic strategies of HCC.
Authors
- Yang Shen (ORCID: https://orcid.org/0000-0002-3313-5062)
- Jiayu Chen
- Le Xu (ORCID: https://orcid.org/0000-0003-4664-3135)
- Ling Wang (ORCID: https://orcid.org/0000-0002-6280-0885)
- Yukai Chen (ORCID: https://orcid.org/0000-0002-9762-3022)
- Ximing Xu (ORCID: https://orcid.org/0000-0002-4240-5378)
- Yangtao Xu (ORCID: https://orcid.org/0009-0001-4404-6110)
- Yuxin Wei
- Shishi Zou
Institutions
- Wuhan University (CN)
- Renmin Hospital of Wuhan University (CN)
Publication Details
- Journal
- International Immunopharmacology
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1016/j.intimp.2025.114762
- Citations
- 2
- Primary Topic
- Peroxisome Proliferator-Activated Receptors
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- National Natural Science Foundation of China